Search Results

There are 117479 results for: content related to: Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin

  1. You have free access to this content
    Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer


    Volume 118, Issue 9, 1 May 2012, Pages: 2385–2393, Soley Bayraktar, Ana M. Gonzalez-Angulo, Xiudong Lei, Aman U. Buzdar, Vicente Valero, Amal Melhem-Bertrandt, Henry M. Kuerer, Gabriel N. Hortobagyi, Aysegul A. Sahin and Funda Meric-Bernstam

    Version of Record online : 27 SEP 2011, DOI: 10.1002/cncr.26555

  2. You have free access to this content
    Trastuzumab-containing regimens for metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Sara Balduzzi, Stefania Mantarro, Valentina Guarneri, Ludovica Tagliabue, Vanna Pistotti, Lorenzo Moja and Roberto D'Amico

    Published Online : 12 JUN 2014, DOI: 10.1002/14651858.CD006242.pub2

  3. You have free access to this content
    Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients


    Volume 118, Issue 10, 15 May 2012, Pages: 2603–2614, Eun-Jung Jung, Libero Santarpia, Juyeon Kim, Francisco J. Esteva, Erica Moretti, Aman U. Buzdar, Angelo Di Leo, Xiao-Feng Le, Robert C. Bast Jr, Soon-Tae Park, Lajos Pusztai and George A. Calin

    Version of Record online : 5 OCT 2011, DOI: 10.1002/cncr.26565

  4. You have free access to this content
    Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer


    Volume 118, Issue 20, 15 October 2012, Pages: 4936–4943, Michelle M. Kim, Shaheenah Dawood, Pamela Allen, Aysegul A. Sahin, Wendy A. Woodward, Benjamin D. Smith, Eric A. Strom, Kelly K. Hunt, Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo and Thomas A. Buchholz

    Version of Record online : 17 APR 2012, DOI: 10.1002/cncr.27502

  5. You have free access to this content
    Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast


    Volume 117, Issue 1, 1 January 2011, Pages: 39–47, Henry M. Kuerer, Aman U. Buzdar, Elizabeth A. Mittendorf, Francisco J. Esteva, Anthony Lucci, Luis M. Vence, Laszlo Radvanyi, Funda Meric-Bernstam, Kelly K. Hunt and William Fraser Symmans

    Version of Record online : 24 AUG 2010, DOI: 10.1002/cncr.25399

  6. You have free access to this content
    Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone


    Volume 98, Issue 7, 1 October 2003, Pages: 1377–1385, Kristine S. Klos, Xiaoyan Zhou, Sangkyou Lee, Lianglin Zhang, Wentao Yang, Yoichi Nagata and Dihua Yu

    Version of Record online : 12 AUG 2003, DOI: 10.1002/cncr.11656

  7. Trastuzumab containing regimens for early breast cancer

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri and Roberto D'Amico

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD006243.pub2

  8. Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 5, May 2010, Pages: 586–592, E C Dijkers, T H Oude Munnink, J G Kosterink, A H Brouwers, P L Jager, J R de Jong, G A van Dongen, C P Schröder, M N Lub-de Hooge and E G de Vries

    Version of Record online : 31 MAR 2010, DOI: 10.1038/clpt.2010.12

  9. You have free access to this content
    Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer


    Volume 120, Issue 13, 1 July 2014, Pages: 1932–1938, Rashmi K. Murthy, Ankur Varma, Priyankana Mishra, Kenneth R. Hess, Elliana Young, James L. Murray, Kimberly H. Koenig, Stacy L. Moulder, Amal Melhem-Bertrandt, Sharon H. Giordano, Daniel Booser, Vicente Valero, Gabriel N. Hortobagyi and Francisco J. Esteva

    Version of Record online : 26 MAR 2014, DOI: 10.1002/cncr.28689

  10. Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 192–201, Chris Wynne, Vernon Harvey, Christian Schwabe, Devonie Waaka, Christine McIntyre and Beate Bittner

    Version of Record online : 22 FEB 2013, DOI: 10.1177/0091270012436560

  11. Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 794–812, Zephania W. Kwong Glover, Lynn Gennaro, Sandeep Yadav, Barthélemy Demeule, Pin Yee Wong and Alavattam Sreedhara

    Version of Record online : 5 DEC 2012, DOI: 10.1002/jps.23403

  12. You have free access to this content
    Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network


    Volume 119, Issue 4, 15 February 2013, Pages: 839–846, Rachel A. Freedman, Melissa E. Hughes, Rebecca A. Ottesen, Jane C. Weeks, Yulei He, Yu-Ning Wong, Richard Theriault and Nancy L. Keating

    Version of Record online : 25 SEP 2012, DOI: 10.1002/cncr.27831

  13. Neoplasms of the Breast

    Standard Article

    Holland-Frei Cancer Medicine

    Hope S. Rugo, Melanie Majure, Anthony Dragun, Meredith Buxton and Laura Esserman

    Published Online : 26 FEB 2017, DOI: 10.1002/9781119000822.hfcm109

  14. You have full text access to this OnlineOpen article
    [64Cu]-labelled trastuzumab: optimisation of labelling by DOTA and NODAGA conjugation and initial evaluation in mice

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 58, Issue 6, 30 May 2015, Pages: 227–233, Christina Schjoeth-Eskesen, Carsten Haagen Nielsen, Søren Heissel, Peter Højrup, Paul Robert Hansen, Nic Gillings and Andreas Kjaer

    Version of Record online : 24 APR 2015, DOI: 10.1002/jlcr.3287

  15. You have free access to this content
    Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: Local stimulation using magnetic microspheres as assessed by quantitative digital microscopy

    Cytometry Part A

    Volume 67A, Issue 2, October 2005, Pages: 161–171, Elza Friedländer, Donna J. Arndt-Jovin, Péter Nagy, Thomas M. Jovin, János Szöllősi and György Vereb

    Version of Record online : 14 SEP 2005, DOI: 10.1002/cyto.a.20173

  16. You have free access to this content
    Adjuvant targeted therapy in early breast cancer


    Volume 115, Issue 6, 15 March 2009, Pages: 1154–1168, John Mackey, Deanna McLeod, Joseph Ragaz, Karen Gelmon, Sunil Verma, Kathleen Pritchard, Kara Laing, Louise Provencher and Lauren F. Charbonneau

    Version of Record online : 22 JAN 2009, DOI: 10.1002/cncr.24114

  17. You have free access to this content
    Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer


    Volume 116, Issue 12, 15 June 2010, Pages: 2856–2867, Helena R. Chang

    Version of Record online : 1 APR 2010, DOI: 10.1002/cncr.25120

  18. You have full text access to this Open Access content
    Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer

    Cancer Science

    Volume 101, Issue 3, March 2010, Pages: 820–825, Nobuyuki Kosaka, Mikako Ogawa, David S. Paik, Chang H. Paik, Peter L. Choyke and Hisataka Kobayashi

    Version of Record online : 31 OCT 2009, DOI: 10.1111/j.1349-7006.2009.01423.x

  19. Pertuzumab: A New Targeted Therapy for HER2-Positive Metastatic Breast Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 1, January 2014, Pages: 60–71, Stephanie J. Malenfant, Karen R. Eckmann and Chad M. Barnett

    Version of Record online : 5 AUG 2013, DOI: 10.1002/phar.1338

  20. Impact of Her-2-Targeted Therapy on Overall Survival in Patients With Her-2 Positive Metastatic Breast Cancer

    The Breast Journal

    Volume 19, Issue 2, March/April 2013, Pages: 149–155, Anna S. Berghoff, Zsuzsanna Bago-Horvath, Peter Dubsky, Margaretha Rudas, Ursula Pluschnig, Christoph Wiltschke, Michael Gnant, Guenther G. Steger, Christoph C. Zielinski and Rupert Bartsch

    Version of Record online : 27 JAN 2013, DOI: 10.1111/tbj.12070